CTI BioPharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Cash & Equivalents	5.04	1.02	0.86	1.48	22.81	Upgrade
Short-Term Investments	0.07	0.06	-	0.02	0.03	Upgrade
Cash & Short-Term Investments	5.11	1.08	0.86	1.51	22.84	Upgrade
Cash Growth	374.65%	25.03%	-42.79%	-93.41%	286.87%	Upgrade
Accounts Receivable	25.79	7.77	-	-	-	Upgrade
Other Receivables	0.93	0.15	-	0	0.81	Upgrade
Receivables	27.88	7.92	-	0	0.81	Upgrade
Inventory	12.07	5.81	-	-	-	Upgrade
Prepaid Expenses	0.15	0.04	0	0.03	-	Upgrade
Other Current Assets	0.01	-	0.46	19.75	-	Upgrade
Total Current Assets	45.22	14.84	1.32	21.28	23.66	Upgrade
Property, Plant & Equipment	0.24	0.28	-	-	0.02	Upgrade
Other Long-Term Assets	0.11	0.11	-	-	-	Upgrade
Total Assets	45.57	15.23	1.32	21.28	23.68	Upgrade
Accounts Payable	29.68	7.29	-	-	-	Upgrade
Accrued Expenses	-	-	0.11	0.16	0.47	Upgrade
Current Portion of Long-Term Debt	5.78	4.87	-	-	-	Upgrade
Current Portion of Leases	0.11	0.09	-	-	0.03	Upgrade
Other Current Liabilities	5.5	1.84	0.02	0.03	0.34	Upgrade
Total Current Liabilities	41.07	14.08	0.13	0.18	0.85	Upgrade
Long-Term Leases	0.11	0.16	-	-	-	Upgrade
Total Liabilities	41.18	14.24	0.13	0.18	0.85	Upgrade
Common Stock	14.79	5.65	1.81	11.2	11.42	Upgrade
Retained Earnings	-11.25	-5.28	-0.62	10.48	11.42	Upgrade
Treasury Stock	-	-	-0	-0	-0	Upgrade
Comprehensive Income & Other	0.85	0.63	0	-0.55	0	Upgrade
Total Common Equity	4.39	0.99	1.2	21.12	22.84	Upgrade
Minority Interest	-0	-	-0	-0.01	-0.01	Upgrade
Shareholders' Equity	4.39	0.99	1.19	21.1	22.83	Upgrade
Total Liabilities & Equity	45.57	15.23	1.32	21.28	23.68	Upgrade
Total Debt	6	5.12	-	-	0.03	Upgrade
Net Cash (Debt)	-0.89	-4.04	0.86	1.51	22.82	Upgrade
Net Cash Growth	-	-	-42.79%	-93.40%	305.08%	Upgrade
Net Cash Per Share	-0.01	-0.03	0.04	0.06	1.07	Upgrade
Filing Date Shares Outstanding	169.77	23.34	23.34	23.81	23.81	Upgrade
Total Common Shares Outstanding	169.77	23.34	23.34	23.81	23.81	Upgrade
Working Capital	4.15	0.77	1.19	21.1	22.81	Upgrade
Book Value Per Share	0.03	0.04	0.05	0.89	0.96	Upgrade
Tangible Book Value	4.39	0.99	1.2	21.12	22.84	Upgrade
Tangible Book Value Per Share	0.03	0.04	0.05	0.89	0.96	Upgrade
Machinery	0.13	0.11	-	-	0.33	Upgrade

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.